Amphastar Pharmaceuticals, Inc. AMPH

26.13 (0.14) (0.53%) as of 25 Sep
Market cap
$1.1B
P/E
15.0×
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
P/E ratio
12.75 11.29 21.93 15.08 17.92 502.75 18.55 0.00 249.61 77.08
P/S ratio
1.74 2.46 4.67 2.74 2.54 2.70 2.81 3.13 3.68 3.29
P/FCF ratio
10.53 10.44 20.71 20.93 15.81 40.67 16,183.62 0.00 144.66 48.87
P/Operating CF
38.09 61.95 125.98 89.92 27.51 56.00 160.35 97.01 90.51 59.93
P/B ratio
1.59 2.46 4.70 2.59 2.50 2.11 2.12 2.53 2.65 2.55
EV/Sales
2.19 2.97 5.18 2.54 2.40 2.52 2.68 2.99 3.58 3.15
EV/EBITDA
7.87 8.23 13.54 9.54 11.25 27.18 47.81 111.51 59.05 26.71
EV/FCF
13.27 12.64 22.99 19.37 14.93 37.95 15,426.84 (221.59) 140.53 46.74
Current Ratio
4.02 3.07 2.17 3.99 3.06 2.49 2.84 2.06 2.79 3.04
Net Debt/EBITDA
1.62 1.43 1.34 (0.77) (0.67) (1.95) (2.35) (5.46) (1.73) (1.22)
Debt/Equity
0.77 0.82 0.92 0.14 0.17 0.10 0.11 0.14 0.14 0.11
ROE
12.90% 23.26% 23.55% 18.76% 13.89% 0.32% 12.36% (1.64%) 1.10% 3.14%
ROA
6.12% 10.32% 12.20% 12.93% 9.54% 0.23% 8.89% (1.19%) 0.83% 2.40%
ROIC
7.88% 11.57% 12.69% 15.76% 11.39% 1.78% (0.01%) (1.68%) (0.26%) 3.28%
Return on Tangible Assets
12.44% 24.26% 25.15% 17.52% 13.55% 0.33% 12.26% (1.77%) 1.21% 3.55%
Average Days of Receivables
81.49 68.83 65.40 65.08 65.81 69.27 51.73 64.67 63.88 38.33
Earnings Yield
7.84% 8.86% 4.56% 6.63% 5.58% 0.20% 5.39% (0.65%) 0.40% 1.30%
Free Cash Flow Yield
9.49% 9.58% 4.83% 4.78% 6.33% 2.46% 0.01% (0.43%) 0.69% 2.05%
Free Cash Flow per Share
2.55 3.56 3.01 1.35 1.48 0.50 0.00 (0.09) 0.13 0.38
Book value per Share
16.88 15.12 13.25 10.89 9.33 9.54 9.10 7.85 7.24 7.26
Free Cash Flow
118.98 172.35 145.34 65.57 70.54 23.41 0.21 (3.97) 6.11 17.18
EV/EBIT
11.23 10.59 16.94 11.78 15.03 80.58 0.00 0.00 0.00 52.22
Other line items

Show all line items

Columns are period end dates